Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stribild for HIV-2 Infection in Senegal
NCT02180438Phase 4Completed
- Sponsor
- University of Washington
- Start
- Sep 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + elvitegravir + cobicistat + tenofovir disoproxil in human immunodeficiency virus type 2 infection (HIV-2), sponsored by University of Washington. Started Sep 2014; status: completed.
02
Drugs
emtricitabine + elvitegravir + cobicistat + tenofovir disoproxil
03
Conditions
human immunodeficiency virus type 2 infection (HIV-2)
Beyond the preview
Go deeper on NCT02180438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02180438.